Oncogene-induced apoptosis in drug-resistant cells
CA 2266955 A1 · Owner: Mccurrach, Mila Elena · Inventors: Fearnhead, Howard O.; Lowe, Scott William; Lazebnik, Yuri
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method of identifying a compound (agent) which modulates apoptosis in transformed cells. In one embodiment the , invention is a method of identifying a compound which selectively activates apoptosis in transformed cells. In an alternative embodiment the present , invention can be used as a method of identifying a compound which inhibits apoptosis in cells. The invention also relates to a method of selectively killing transformed cells, wherein the transformed cell is contacted with a compound which selectively activates apoptosis in transformed cells as , described herein. The invention also relates to methods of treating diseases associated with …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 26, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.